With the advancement of medical insurance, medical treatment, and pharmaceutical informatization, the management of medical insurance services has gradually undergone the transformation of informatization and digitization. The traditional paper prescription circulation method is difficult to meet the demands of modern medical services, and the establishment and standardized management of the medical insurance electronic prescription circulation platform based on the Internet hospitals have gained consensus among all stakeholders. In this context, the construction of the medical insurance electronic prescription circulation platform has emerged in order to enhance the efficiency of medical insurance management and better cater to the accessibility and convenience of medical treatment and drug purchase for the insured. In comparison with the low efficiency, high cost, susceptibility to errors, and lack of transparency in prescription information associated with traditional paper prescription circulation, electronic prescription circulation demonstrates some obvious advantages. To improve multi-channel drug procurement guarantees for the insured with the implementation of national drug negotiation's "dual-channel" policy, constructing a medical insurance drug electronic prescription circulation platform will effectively enhance the efficiency of management services while improving insured individuals' sense of satisfaction. This paper systematically analyzes Nanjing Medical Insurance Electronic Prescription Circulation Platform's construction, design and implementation, summarizes the effects of operating and managing this platform while analyzing the problems, and proposes to construct the platform with a focus on "intelligent connection" and "cloud transfer".
Key words
electronic prescription circulation /
platform construction /
medical insurance department /
hospitals /
retail pharmacies
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 国家卫生健康委员会,国家中医药管理局.关于印发互联网诊疗管理办法(试行)等3个文件的通知:国卫医发〔2018〕25号[EB/OL].(2018-07-17)[2024-06-01].https://www.gov.cn/gongbao/content/2019/content_5358684.htm.
[2] 范瑞雪,袁孝青,杜玉馨,等.我国电子处方流转现状及对策[J].中国药业,2022,31(17):1-6.
[3] 何坤,张丽青.“互联网+慢性病管理”模式下处方外流的发展机遇与挑战分析[J].卫生职业教育,2021,39(12):152-154.
[4] 广东省药学会.互联网医院处方流转平台规范化管理专家共识[J].今日药学. 2020,30(11): 721-727.
[5] 李欣雨,徐娟.我国医保谈判药品“双通道”管理政策执行困境及推进策略[J].中国药房. 2024,35(8):906-911.
[6] 周玉涛. 处方共享平台:重构处方药品流通生态[J].中国药店,2019(12):46-47.
[7] 周玉涛.电子处方:医药分家的必要条件[J].中国药店,2017(7):42-43.
[8] 刘德阳,王静,周乃彤,等.我国电子处方服务模式现状与发展[J].中国药房,2021,32(1):5-12.